Related Experiment Video
Updated: Feb 27, 2026

09:16
Simultaneous Study of the Recruitment of Monocyte Subpopulations Under Flow In Vitro
Published on: November 26, 2018
7.6K
Monocyte subpopulations study in patients with plaque psoriasis
Mariana Carvalho Costa1, Bruno de Oliveira Rocha2, Camilla Sampaio Paixão2
1Faculty of Medicine, University of Brasília, Brazil.
Medical Hypotheses
|July 5, 2017
Summary
Psoriasis patients show altered frequencies of monocyte subpopulations in both blood and skin lesions. These changes correlate with disease severity, suggesting monocytes are key players in psoriasis pathogenesis.
Area of Science:
- Immunology
- Dermatology
- Inflammation
Background:
- Psoriasis is a chronic, immune-mediated inflammatory disease impacting quality of life.
- Monocytes play a crucial role in immune responses by presenting antigens to T-lymphocytes.
- Monocytes are classified into classical, intermediate, and non-classical subsets based on CD14 and CD16 expression.
Purpose of the Study:
- To determine the frequency of monocyte subpopulations in the blood and lesional skin of plaque psoriasis patients.
- To investigate the association between monocyte subset frequencies, cytokine levels, and psoriasis clinical severity.
Main Methods:
- Flow cytometry was used to analyze monocyte subpopulations (classical, intermediate, non-classical) using CD14 and CD16 antibodies.
- Analysis was performed on peripheral blood and lesional skin samples from plaque psoriasis patients.
- Cytokine levels and clinical disease severity were assessed and correlated with monocyte subset frequencies.
Main Results:
- Psoriasis patients exhibited altered frequencies of intermediate (CD14++CD16+) and non-classical (CD14+CD16++) monocyte subsets compared to healthy controls.
- These subsets were found in both blood and lesional skin.
- Specific monocyte subset frequencies were significantly associated with certain cytokine profiles and clinical measures of disease severity.
Conclusions:
- Monocyte subpopulations are dysregulated in psoriasis, appearing in both blood and affected skin.
- The findings suggest that intermediate and non-classical monocytes may contribute to psoriasis pathogenesis.
- Further research into targeting these monocyte subsets could offer novel therapeutic strategies for psoriasis.

